Table of Contents Author Guidelines Submit a Manuscript
Evidence-Based Complementary and Alternative Medicine
Volume 2015, Article ID 582437, 10 pages
http://dx.doi.org/10.1155/2015/582437
Research Article

Type I Saikosaponins A and D Inhibit Osteoclastogenesis in Bone Marrow-Derived Macrophages and Osteolytic Activity of Metastatic Breast Cancer Cells

1Department of Applied Life Science, The Graduate School, Yonsei University, 50 Yonsei-ro, Seodaemun-gu, Seoul 120-749, Republic of Korea
2Department of Oral Biology, Oral Cancer Research Institute and BK21 PLUS Project, Yonsei University College of Dentistry, 50-1 Yonsei-ro, Seodaemun-gu, Seoul 120-752, Republic of Korea
3Department of Dental Hygiene, Kyungpook National University, Sangju 742-711, Republic of Korea
4Department of Dentistry, The Graduate School, Yonsei University, 50 Yonsei-ro, Seodaemun-gu, Seoul 120-749, Republic of Korea

Received 17 December 2014; Accepted 9 March 2015

Academic Editor: Sonia Piacente

Copyright © 2015 Ji-Eun Shin et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. K. Väänänen, “Mechanism of osteoclast mediated bone resorption—rationale for the design of new therapeutics,” Advanced Drug Delivery Reviews, vol. 57, no. 7, pp. 959–971, 2005. View at Publisher · View at Google Scholar · View at Scopus
  2. H. J. Häuselmann and R. Rizzoli, “A comprehensive review of treatments for postmenopausal osteoporosis,” Osteoporosis International, vol. 14, no. 1, pp. 2–12, 2003. View at Publisher · View at Google Scholar · View at Scopus
  3. E. Seeman, “Reduced bone formation and increased bone resorption: rational targets for the treatment of osteoporosis,” Osteoporosis International, vol. 14, supplement 3, pp. S2–S8, 2003. View at Google Scholar · View at Scopus
  4. B. Erdogan and I. Cicin, “Medical treatment of breast cancer bone metastasis: from bisphosphonates to targeted drugs,” Asian Pacific Journal of Cancer Prevention, vol. 15, no. 4, pp. 1503–1510, 2014. View at Publisher · View at Google Scholar · View at Scopus
  5. A. Wattel, S. Kamel, R. Mentaverri et al., “Potent inhibitory effect of naturally occurring flavonoids quercetin and kaempferol on in vitro osteoclastic bone resorption,” Biochemical Pharmacology, vol. 65, no. 1, pp. 35–42, 2003. View at Publisher · View at Google Scholar · View at Scopus
  6. H. Ma, X. He, Y. Yang, M. Li, D. Hao, and Z. Jia, “The genus epimedium: an ethnopharmacological and phytochemical review,” Journal of Ethnopharmacology, vol. 134, no. 3, pp. 519–541, 2011. View at Publisher · View at Google Scholar · View at Scopus
  7. J. N. Wu, An Illustrated Chinese Materia Medica, Oxford University Press, New York, NY, USA, 2005.
  8. L. J. Fundukian, The Gale Encyclopedia of Alternative Medicine, Gale Cengage Learning, Detroit, Mich, USA, 3rd edition, 2009.
  9. World Health Organization, Medicinal Plants in China: A Selection of 150 Commonly Used Species, World Health Organization, Regional Office for the Western Pacific, Manila, Philippines, 1997.
  10. World Health Organization, Medicinal Plants in the Republic of Korea: Information on 150 Commonly Used Medicinal Plants, Regional Office for the Western Pacific, World Health Organization, Manila, Philippines, 1998.
  11. H.-Q. Huang, X. Zhang, M. Lin, Y.-H. Shen, S.-K. Yan, and W.-D. Zhang, “Characterization and identification of saikosaponins in crude extracts from three Bupleurum species using LC-ESI-MS,” Journal of Separation Science, vol. 31, no. 18, pp. 3190–3201, 2008. View at Publisher · View at Google Scholar · View at Scopus
  12. P. Wang, J. Ren, J. Tang, D. Zhang, B. Li, and Y. Li, “Estrogen-like activities of saikosaponin-d in vitro: a pilot study,” European Journal of Pharmacology, vol. 626, no. 2-3, pp. 159–165, 2010. View at Publisher · View at Google Scholar · View at Scopus
  13. M. L. Ashour and M. Wink, “Genus Bupleurum: a review of its phytochemistry, pharmacology and modes of action,” The Journal of Pharmacy and Pharmacology, vol. 63, no. 3, pp. 305–321, 2011. View at Publisher · View at Google Scholar · View at Scopus
  14. K. Ohuchi, M. Watanabe, T. Ozeki, and S. Tsurufuji, “Pharmacological influence of saikosaponins on prostaglandin E2 production by peritoneal macrophages,” Planta Medica, vol. 3, pp. 208–212, 1985. View at Google Scholar · View at Scopus
  15. R. Kyo, N. Nakahata, Y. Kodama, Y. Nakai, M. Kubo, and Y. Ohizumi, “Antagonism of Saikosaponin-induced prostaglandin E2 release by baicalein in C6 rat glioma cells,” Biological & Pharmaceutical Bulletin, vol. 22, no. 12, pp. 1385–1387, 1999. View at Publisher · View at Google Scholar · View at Scopus
  16. K.-G. Shyu, S.-C. Tsai, B.-W. Wang, Y.-C. Liu, and C.-C. Lee, “Saikosaponin C induces endothelial cells growth, migration and capillary tube formation,” Life Sciences, vol. 76, no. 7, pp. 813–826, 2004. View at Publisher · View at Google Scholar · View at Scopus
  17. Z.-P. Zong, K. Fujikawa-Yamamoto, M. Tanino, K. Teraoka, H. Yamagishi, and S. Odashima, “Saikosaponin b2-induced apoptosis of cultured B16 melanoma cell line through down-regulation of PKC activity,” Biochemical and Biophysical Research Communications, vol. 219, no. 2, pp. 480–485, 1996. View at Publisher · View at Google Scholar · View at Scopus
  18. J. C. Chen, N. W. Chang, J. G. Chung, and K. C. Chen, “Saikosaponin-A induces apoptotic mechanism in human breast MDA-MB-231 and MCF-7 cancer cells,” The American Journal of Chinese Medicine, vol. 31, no. 3, pp. 363–377, 2003. View at Publisher · View at Google Scholar · View at Scopus
  19. B. M. Kim and S. H. Hong, “Sequential caspase-2 and caspase-8 activation is essential for saikosaponin a-induced apoptosis of human colon carcinoma cell lines,” Apoptosis, vol. 16, no. 2, pp. 184–197, 2011. View at Publisher · View at Google Scholar · View at Scopus
  20. B.-F. Wang, X.-J. Wang, H.-F. Kang et al., “Saikosaponin-D enhances radiosensitivity of hepatoma cells under hypoxic conditions by inhibiting hypoxia-inducible factor-1α,” Cellular Physiology and Biochemistry, vol. 33, no. 1, pp. 37–51, 2014. View at Publisher · View at Google Scholar · View at Scopus
  21. R. Y. Liu and J. P. Li, “Saikosaponin-d inhibits proliferation of human undifferentiated thyroid carcinoma cells through induction of apoptosis and cell cycle arrest,” European Review for Medical and Pharmacological Sciences, vol. 18, no. 17, pp. 2435–2443, 2014. View at Google Scholar
  22. J.-Q. Yu, A.-J. Deng, L.-Q. Wu et al., “Osteoclast-inhibiting saikosaponin derivatives from Bupleurum Chinense,” Fitoterapia, vol. 85, no. 1, pp. 101–108, 2013. View at Publisher · View at Google Scholar · View at Scopus
  23. K. D. Yoon and J. Kim, “Application of centrifugal partition chromatography coupled with evaporative light scattering detection for the isolation of saikosaponins-a and -c from Bupleurum falcatum roots,” Journal of Separation Science, vol. 32, no. 1, pp. 74–78, 2009. View at Publisher · View at Google Scholar · View at Scopus
  24. J. Lee, D.-H. Yang, J. H. Suh et al., “Species discrimination of Radix Bupleuri through the simultaneous determination of ten saikosaponins by high performance liquid chromatography with evaporative light scattering detection and electrospray ionization mass spectrometry,” Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences, vol. 879, no. 32, pp. 3887–3895, 2011. View at Publisher · View at Google Scholar · View at Scopus
  25. S. K. Lee, K. K. Park, J. H. Y. Park, S. S. Lim, and W.-Y. Chung, “The inhibitory effect of roasted licorice extract on human metastatic breast cancer cell-induced bone destruction,” Phytotherapy Research, vol. 27, no. 12, pp. 1776–1783, 2013. View at Publisher · View at Google Scholar · View at Scopus
  26. Y.-Y. Kong and J. M. Penninger, “Molecular control of bone remodeling and osteoporosis,” Experimental Gerontology, vol. 35, no. 8, pp. 947–956, 2000. View at Publisher · View at Google Scholar · View at Scopus
  27. J.-M. Delaissé, T. L. Andersen, M. T. Engsig, K. Henriksen, T. Troen, and L. Blavier, “Matrix metalloproteinases (MMP) and cathepsin K contribute differently to osteoclastic activities,” Microscopy Research and Technique, vol. 61, no. 6, pp. 504–513, 2003. View at Publisher · View at Google Scholar · View at Scopus
  28. Y. Qian and H.-Z. Huang, “The role of RANKL and MMP-9 in the bone resorption caused by ameloblastoma,” Journal of Oral Pathology & Medicine, vol. 39, no. 8, pp. 592–598, 2010. View at Publisher · View at Google Scholar · View at Scopus
  29. J.-M. Delaissé, M. T. Engsig, V. Everts et al., “Proteinases in bone resorption: obvious and less obvious roles,” Clinica Chimica Acta, vol. 291, no. 2, pp. 223–234, 2000. View at Publisher · View at Google Scholar · View at Scopus
  30. T. Ohshiba, C. Miyaura, M. Inada, and A. Ito, “Role of RANKL-induced osteoclast formation and MMP-dependent matrix degradation in bone destruction by breast cancer metastasis,” British Journal of Cancer, vol. 88, no. 8, pp. 1318–1326, 2003. View at Publisher · View at Google Scholar · View at Scopus
  31. M. J. Bossard, T. A. Tomaszek, S. K. Thompson et al., “Proteolytic activity of human osteoclast cathepsin K. Expression, purification, activation, and substrate identification,” Journal of Biological Chemistry, vol. 271, no. 21, pp. 12517–12524, 1996. View at Publisher · View at Google Scholar · View at Scopus
  32. S. R. Wilson, C. Peters, P. Saftig, and D. Brömme, “Cathepsin K activity-dependent regulation of osteoclast actin ring formation and bone resorption,” The Journal of Biological Chemistry, vol. 284, no. 4, pp. 2584–2592, 2009. View at Publisher · View at Google Scholar · View at Scopus
  33. J. Y. Gauthier, N. Chauret, W. Cromlish et al., “The discovery of odanacatib (MK-0822), a selective inhibitor of cathepsin K,” Bioorganic & Medicinal Chemistry Letters, vol. 18, no. 3, pp. 923–928, 2008. View at Publisher · View at Google Scholar · View at Scopus
  34. D. Chappard, H. Libouban, L. Mindeholm, M. F. Baslé, E. Legrand, and M. Audran, “The Cathepsin K inhibitor AAE581 induces morphological changes in osteoclasts of treated patients,” Microscopy Research and Technique, vol. 73, no. 7, pp. 726–732, 2010. View at Publisher · View at Google Scholar · View at Scopus
  35. G. R. Mundy, “Metastasis to bone: causes, consequences and therapeutic opportunities,” Nature Reviews Cancer, vol. 2, no. 8, pp. 584–593, 2002. View at Publisher · View at Google Scholar · View at Scopus
  36. A. Chiechi, D. L. Waning, K. R. Stayrook, J. T. Buijs, T. A. Guise, and K. S. Mohammad, “Role of TGF-β in breast cancer bone metastases,” Advances in Bioscience and Biotechnology, vol. 4, no. 10C, pp. 15–30, 2013. View at Publisher · View at Google Scholar